Loading data...
Loading data...
Unlike semiconductors or rare earths, there is no single point of failure in this graph — and that's worth learning from. Moderna and Pfizer backed themselves with multiple real manufacturing partners at once. That was a deliberate choice, not luck.
Press Play and watch the map build itself scene by scene — suppliers, customers, competitors, and a failure simulation, all straight from the real graph.
Moderna → Lonza Group
In May 2020, Moderna and Lonza announced a 10-year strategic collaboration to manufacture Moderna's COVID-19 vaccine (mRNA-1273) at Lonza facilities in the U.S. and Switzerland, aiming to enable production of up to 1 billion doses per year. Lonza was a primary scale-up manufacturing partner, not Moderna's only one.
Vaccine Glass Vials
Required by: Moderna, Pfizer
In June 2020, the U.S. Departments of Defense and Health and Human Services awarded Corning $204 million under Operation Warp Speed to rapidly expand domestic production of its Valor Glass vials — designed to fill up to 50% faster and be up to 10 times stronger than traditional vials. Corning was a major, government-selected supplier, not the world's only vial maker.
The network map below is the real graph, not an illustration. Every node and every line is clickable.
👆 Click any company on the map to see what happens if it "fails", or click a connecting line to see the evidence behind it.
Pick a node to fail:
Select a node above, click one directly on the map, or just click "Show me an example."
Impact is marked "confirmed" only once every known alternative supplier for that component is also down. "Secondary" exposure flags a dependency edge with no known sole-source alternative. The dark-red nodes on the map are structural single points of failure in the graph itself — independent of whatever you simulate.
Counted directly from the graph — not an AI-generated score. Notice: nobody here is "without an alternative" — that's itself the finding.
Moderna ↔ Pfizer
Moderna and Pfizer were the two dominant developers of mRNA-based COVID-19 vaccines, both authorized and distributed at massive scale starting in December 2020.
A real business description, StockIQ's current score, and the latest real headlines for each company.
Corning
GLW · Information Technology
No score available
No description available.
Yahoo · Bet on These Photonics ETFs to Exploit the Next Wave of AI Revolution · today
Yahoo · Netflix, Nucor, On Holding, Xenon, Accenture, Coinbase, and More Stocks That Explain Today’s Market · today
Lonza Group
LZAGY
83
A-
No description available.
SeekingAlpha · Lonza Group AG (LZAGY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript · 3d ago
MT Newswires · BridgeBio Pharma Doses First Patient in Trial Evaluating Long-Term Impact of Heart Disease Medicine · 23d ago
Moderna
This is the sixth pilot of the X-Ray engine — a hand-curated, documented dependency graph for the pandemic-era medical supply chain only. Every relationship is backed by a well-known public industry fact; none of it was generated by AI. This information should not be considered investment advice.
MRNA · Health Care
No score available
No description available.
Yahoo · Dow Jones Futures: Market Still Choppy; Robinhood, Sandisk, AMD, Moderna Surge Into Buy Areas · today
Yahoo · Axsome Therapeutics vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026? · today
Pfizer
PFE · Health Care
No score available
No description available.
Yahoo · All 50 States Joining Medicaid Drug Pricing Model After Pharma Deals, Trump Says · today
Yahoo · What Would It Take For Eli Lilly Stock To Keep Climbing? · today